Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Tribune News Service
Tribune News Service
Sport
Dennis Lin

Jarred Cosart out for rest of 2017 after arthroscopic surgery

Another injury-plagued season has come to an end for Jarred Cosart. The Padres right-hander underwent arthroscopic elbow surgery early this week and will be sidelined for the remainder of 2017, manager Andy Green said. The cleanup procedure is the second Cosart has had since the end of last season.

Cosart is expected to be ready for the start of 2018, though he could be a non-tender candidate this winter. The 27-year-old will be eligible for salary arbitration, and his Padres tenure has been marred by inconsistency and multiple stints on the disabled list.

Acquired from Miami last July, Cosart posted a 6.03 ERA in nine starts before going down with elbow inflammation in September. On Oct. 19, he had a bone spur in the elbow surgically removed.

Cosart, who also dealt with blisters in 2016, opened this season in the bullpen, moved to the rotation when Trevor Cahill went on the disabled list and re-encountered the injury bug himself. He exited an April 18 start with a strained hamstring. After a month, he returned to make four more starts before an elbow strain landed him on the shelf.

Green did not provide further details on Cosart's latest operation.

In seven 2017 appearances, including six starts, Cosart logged a 4.88 ERA and more walks than strikeouts. If the Padres trade a starter before August, options to join the rotation include Triple-A El Paso's Michael Kelly and Dillon Overton. Rookie Miguel Diaz, who is on the DL because of a forearm strain, is playing long toss but has not yet thrown off a mound.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.